DJ DexCom Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of DexCom Inc. $(DXCM)$ rose 1.51% to $88.78 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.39% to 6,061.48 and the Dow Jones Industrial Average rising 0.71% to 44,873.28.
This was the stock's third consecutive day of gains.
DexCom Inc. closed 37.48% short of its 52-week high of $142.00, which the company reached on March 26th.
The stock underperformed when compared to some of its competitors Wednesday, as Abbott Laboratories $(ABT)$ rose 2.29% to $132.06 and Insulet Corp. $(PODD)$ rose 2.23% to $284.70.
Trading volume (2.0 M) remained 1.4 million below its 50-day average volume of 3.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled February 5, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 05, 2025 16:57 ET (21:57 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。